Aqua Bio Technology ASA (OSTO:ABTO) EBIT: kr-1.53 Mil (TTM As of Dec. 2025)


OSTO:ABTO Aqua Bio Technology ASA OSTO:ABTO
29 GF Score
Price kr6.82
GF Value kr3.37
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Aqua Bio Technology ASA EBIT?

Aqua Bio Technology ASA OSTO:ABTO 29 EBIT is kr-1.53 Mil as of Dec. 2025. GuruFocus rates OSTO:ABTO with a GF Score™ of 29/100 and a GF Value™ of kr3.37 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Aqua Bio Technology ASA's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2025 was kr-0.15 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was kr-1.53 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Aqua Bio Technology ASA's annualized ROC % for the quarter that ended in Dec. 2025 was -2.95%. Aqua Bio Technology ASA's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was -91.69%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Aqua Bio Technology ASA's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was -0.85%.


Aqua Bio Technology ASA  (OSTO:ABTO) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Aqua Bio Technology ASA's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=-7.436 * ( 1 - 0% )/( (257.336 + 247.319)/ 2 )
=-7.436/252.3275
=-2.95 %

where

Note: The Operating Income data used here is four times the quarterly (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Aqua Bio Technology ASA's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-0.612/( ( (1.296 + max(-20.2, 0)) + (0.039 + max(-20.391, 0)) )/ 2 )
=-0.612/( ( 1.296 + 0.039 )/ 2 )
=-0.612/0.6675
=-91.69 %

where Working Capital is:

Working Capital(Q: Sep. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(6.503 + 2.4 + 0.186) - (16.041 + 0 + 13.248)
=-20.2

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.065 + 0 + 0.333) - (8.981 + 0 + 11.808)
=-20.391

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Aqua Bio Technology ASA's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2025 )
=-1.531/180.211
=-0.85 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aqua Bio Technology ASA EBIT Related Terms


Aqua Bio Technology ASA EBIT Historical Data

* Premium members only.

The historical data trend for Aqua Bio Technology ASA's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aqua Bio Technology ASA EBIT Chart

Aqua Bio Technology ASA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -17.66 -16.51 -16.36 -110.41 -12.42

Aqua Bio Technology ASA Quarterly Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Sep24 Dec24 Jun25 Sep25 Dec25
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -70.02 -22.65 0.00 -1.38 -0.15

OSTO:ABTO vs VRTX, REGN, ALNY: EBIT Comparison

For the Biotechnology subindustry, Aqua Bio Technology ASA's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aqua Bio Technology ASA EV-to-EBIT vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aqua Bio Technology ASA's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Aqua Bio Technology ASA's EV-to-EBIT falls into.


OSTO:ABTO
29GF Score
Aqua Bio Technology ASA OSTO:ABTO
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aqua Bio Technology ASA EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-1.53 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of kr-1.53 Mil mean?
Aqua Bio Technology ASA (OSTO:ABTO) has a EBIT of kr-1.53 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Aqua Bio Technology ASA.
Is Aqua Bio Technology ASA's EBIT too high?
Aqua Bio Technology ASA's current EBIT is kr-1.53 Mil. Overall, Aqua Bio Technology ASA has a GF Score™ of 29/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aqua Bio Technology ASA's EBIT compare to VRTX and REGN?
Aqua Bio Technology ASA's EBIT of kr-1.53 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Biotechnology company?
A good EBIT depends on the Biotechnology industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Aqua Bio Technology ASA. Aqua Bio Technology ASA's current EBIT is kr-1.53 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aqua Bio Technology ASA stock overvalued right now?
Based on GuruFocus' analysis, Aqua Bio Technology ASA (OSTO:ABTO) is currently considered Significantly Overvalued. The stock's GF Value™ is kr3.37, compared to a current price of kr6.82 — trading 102.4% above its estimated fair value. The current EBIT is kr-1.53 Mil. Aqua Bio Technology ASA's overall GF Score™ is 29/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Aqua Bio Technology ASA (OSTO:ABTO), the current EBIT is kr-1.53 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aqua Bio Technology ASA (OSTO:ABTO) Overvalued in 2026?

Based on GuruFocus' analysis, Aqua Bio Technology ASA stock appears to be overvalued. The current stock price of kr6.82 is trading 102.4% above its estimated GF Value™ of kr3.37. GuruFocus considers Aqua Bio Technology ASA to be Significantly Overvalued.

Key valuation signals for OSTO:ABTO:

  • EBIT: kr-1.53 Mil
  • GF Value™: kr3.37 vs. price of kr6.82 (102.4% above fair value)
  • GF Score™: 29/100 with 5 warning signs

No single metric tells the full story. See the OSTO:ABTO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Aqua Bio Technology ASA Business Description

Address Bygdoy Alle, Oslo, NOR, 0257
Aqua Bio Technology ASA develops, produces and markets active ingredients for the personal care industry. It creates products for personal care, healthcare, and cosmetics with the help of marine biotechnology. ABT's brands include Moana-Organic skin care and Cuvget-Arctic skin care.
29GF Score

Get the complete analysis for OSTO:ABTO

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr6.82
Price
kr3.37
GF Value